Erin M Steinbrink, CRNA | |
9100 W 74th St, Shawnee Mission, KS 66204-4004 | |
(913) 632-2230 | |
(913) 632-2297 |
Full Name | Erin M Steinbrink |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 11 Years |
Location | 9100 W 74th St, Shawnee Mission, Kansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174963649 | NPI | - | NPPES |
49689018 | Other | KS | BCBS KC |
201074900A | Medicaid | KS | |
P01268487 | Other | KS | RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 557183 (Kansas) | Primary |
163W00000X | Registered Nurse | 98288 (Kansas) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Midwest Anesthesia Associates, Pa | 4981597838 | 83 |
News Archive
A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.
Mayo Clinic researchers have discovered a way to dramatically boost the output of immune system cells from the thymus, which may lead to improved cancer vaccines, as well as to ways to otherwise strengthen immune responses.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.
› Verified 6 days ago
Entity Name | Midwest Anesthesia Associates, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336192392 PECOS PAC ID: 4981597838 Enrollment ID: O20040204000690 |
News Archive
A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.
Mayo Clinic researchers have discovered a way to dramatically boost the output of immune system cells from the thymus, which may lead to improved cancer vaccines, as well as to ways to otherwise strengthen immune responses.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Erin M Steinbrink, CRNA Po Box 411895, Kansas City, MO 64141-1895 Ph: (913) 632-2230 | Erin M Steinbrink, CRNA 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 632-2230 |
News Archive
A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.
Mayo Clinic researchers have discovered a way to dramatically boost the output of immune system cells from the thymus, which may lead to improved cancer vaccines, as well as to ways to otherwise strengthen immune responses.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.
› Verified 6 days ago
Robb A. Aerni, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2679 Fax: 913-789-3191 | |
Lisa A Noyes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Marlene F. Bailey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Sarah-grace Miller Hamm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Stephanie A. Klamm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2679 Fax: 913-789-3191 | |
Danelle Lynn Diorio, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 |